EXPEDIENCY OF MARKERS FOR EARLY DETECTION OF ACUTE KIDNEY INJURY SEQUELAE TO TYPE 2 DIABETES MELLITUS

Authors

  • MuniLakshmi u PhD ScholarDepartment of BiochemistrySri Devaraj Urs Medical CollegeTamakaKolar
  • Shashidhar Kn
  • Muninarayana C
  • Madhavi Reddy
  • Lakshmaiah V

Abstract

ABSTRACT
Objective: Estimation of Cystatin C (Cys C), traditional markers, inflammatory, and endothelial cell activation markers can identify subjects who are
at increased risk for future acute kidney injury (AKI) after diabetes.
Methods: A total of 210 subjects, having 70 subjects in each group between the age group of 45-75 years were enrolled in our study.
Results: Body mass index (BMI), obesity index, waist circumference, and waist–hip ratio higher in Group III and Group II compared to Group I with a
significant p<0.001. All the biochemical parameters were significantly higher in Group III compared to Group I and Group II with a narrow difference
between Group III and Group II. Serum Cys C was significantly correlated with creatinine and NO. Whereas serum creatinine (SCr) shows strong
positive correlation with BMI, fasting blood sugar, HbA1c, NO, and high-sensitivity C-reactive protein. Estimated glomerular filtration rate (eGFR) and
triglycerides show inverse relation to creatinine with a significant p-value. The serum Cys C showed an area under the curve (AUC) of 0.950 with a
cutoff value of 1.06, SCr with an AUC of 0.617, and eGFR with AUC of 0.588.
Conclusion: Elevated levels of biomarker Cys C, SCr, and albumin-creatinine ratio are predictors of AKI in the setting of diabetes. Baseline inflammatory
and endothelial activation markers may also be useful for predicting future risk of AKI in diabetes mellitus. Hopefully, the advent of new biomarkers
will help defining the kidney at risk rather than relying simply on creatinine. To date, none of the new AKI biomarkers have undergone a similar
rigorous assessment, but the current progress will hopefully lead to success and ultimately to improvement in patient outcome.
Keywords: Type 2 diabetes mellitus, Acute kidney injury, Biomarkers, Inflammation, Endothelium.

Downloads

Download data is not yet available.

Author Biography

MuniLakshmi u, PhD ScholarDepartment of BiochemistrySri Devaraj Urs Medical CollegeTamakaKolar

Department of Biochemistry

PhD Scholar

References

REFERENCES

Kasper DI, Fauci AS, Hauser SL, Longo DL, Jameson JL. Acute renal

failure. In: Harrison TR, editor. Principles of Internal Medicine. 18

ed.,

Vol. 2. New York: McGraw Hill; 2012. p. 2293-6.

Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S,

et al. Acute renal failure in critically ill patients: A multinational,

multicenter study. JAMA 2005;294(7):813-8.

Sabbisetti V, Joseph VB. Biomarkers in acute and chronic kidney

diseases. In: Brenner and Rector’s the Kidney. 9

ed., Vol. 1. USA:

Elsevier Saunders; 2012. p. 1016-43.

th

Himmelfarb J, McMonagle E, Freedman S, Klenzak J, McMenamin E,

Le P, et al. Oxidative stress is increased in critically ill patients with

acute renal failure. J Am Soc Nephrol 2004;15(9):2449-56.

Carmen M, Navarro JF. From the Nephrology Service and Research

Unit. Tenerife, Spain: Hospital Universitario Nuestra Senora de

Candelaria, Santa Cruz de Tenerife; 2004.

Han WK, Bonventre JV. Biologic markers for the early detection of

acute kidney injury. Curr Opin Crit Care 2004;10(6):476-82.

Brzin J, Popovic T, Turk V, Borchart U, Machleidt W. Human cystatin,

A new protein inhibitor of cysteine proteinases. Biochem Biophys Res

Commun 1984;118(7):103-9.

Barrett AJ, Davies ME, Grubb A. The place of human gamma-trace

(cystatin C) amongst the cysteine proteinase inhibitors. Biochem

Biophys Res Commun 1984;120(2):631-6.

Kaseda R, Iino N, Hosojima M, Takeda T, Hosaka K, Kobayashi A,

et al. Megalin-mediated endocytosis of cystatin C in proximal tubule

cells. Biochem Biophys Res Commun 2007;357:1130-4.

Mehta RL, Kellum JA, Shah S, Molitoris BA. AKIN Summit. AKIN:

Acute Kidney Injury Network: Report of an Initiative. Amsterdam:

AKIN; 2006.

Munilakshmi U, Shashidhar KN, Harish R, Reddy M, Lakshmaiah V.

Biochemical evaluation, anthropometric measurements in assessment

of micro vascular complications in females with Type-2 diabetes

mellitus. Asian J Med Sci 2014;5(2):113-9.

Giustarinin D, Rossi R, Milzani A, Dalle-Donne I. Nitrite and nitrate

measurement by Griess reagent in human Plasma: Evaluation of

th

interferences and standardization. Methods Enzymol 2008;440:361-80.

Ridker PM. High-sensitivity C-reactive protein: Potential adjunct for

global risk assessment in the primary prevention of cardiovascular

disease. Circulation 2001;103(3):1813-8.

Nurten T, Husamettin E, Ilgım S. Measurement of total malondialdehyde

in plasma and tissues by high-performance liquid chromatography and

thiobarbituric acid assay. Fırat Tıp Dergisi 2006;11(2):88-92.

Karlsen A, Blomhoff R, Gundersen TE. Stability of whole blood and

plasma ascorbic acid. Eur J Clin Nutr 2007;61(10):1233-6.

Ekiel I, Abrahamson M, Fulton DB, Lindahl P, Storer AC, Levadoux W,

et al. NMR structural studies of human cystatin C dimers and monomers.

J Mol Biol 1997;271(2):266-77.

Shashidhar KN, Munilakshmi U, Prabhavathi K, Reddy M,

Lakshmaiah V. Potential role of uric acid in correlation with epidemics

of hypertension and albumin creatinine ratio in diabetic nephropathy.

Apollo Med 2015. DOI:10.1016/J.APME.2015.07.011.

Arner P. Insulin resistance in type 2 diabetes: Role of fatty acids.

Diabetes Metab Res Rev 2002;18 Suppl 2:S5-9.

Shimada M, Dass B, Ejaz AA. Paradigm shift in the role of uric acid in

acute kidney injury. Semin Nephrol 2011;31(5):453-8.

Navarro JF, Milena FJ, Mora C, León C, García J. Renal proinflammatory

cytokine

gene

expression

in diabetic

nephropathy:

Effect

of angiotensin-converting

enzyme

inhibition and

pentoxifylline

administration.

Am

J Nephrol 2006;26(6):562-70.

Pou KM, Massaro JM, Hojjman U, Vasan RS, Maurovich HP,

Larson MG., et al. Visceral and sub cutaneous adipose tissue volumes

are cross sectionally related to markers of inflammation and oxidative

stress: The Framingham Heart study. Circulation 2007;116:1234-41.

Tesch GH. Role of macrophages in complications of type 2 diabetes.

Clin Exp Pharmacol Physiol 2007;34(10):1016-9.

Zhang Z, Lu B, Sheng X, Jin N. Cystatin C in prediction of acute

kidney injury: A systemic review and meta-analysis. Am J Kidney Dis

;58(3):356-65.

Royakkers AA, Korevaar JC, van Suijlen JD, Hofstra LS, Kuiper MA,

Spronk PE, et al. Serum and urine cystatin C are poor biomarkers for

acute kidney injury and renal replacement therapy. Intensive Care Med

;37(3):493-501.

Published

01-07-2016

How to Cite

MuniLakshmi u, S. Kn, M. C, M. Reddy, and L. V. “EXPEDIENCY OF MARKERS FOR EARLY DETECTION OF ACUTE KIDNEY INJURY SEQUELAE TO TYPE 2 DIABETES MELLITUS”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 4, July 2016, pp. 168-72, https://mail.innovareacademics.in/journals/index.php/ajpcr/article/view/11884.

Issue

Section

Original Article(s)